Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001472301 | SCV001676430 | likely benign | Pancreatic adenocarcinoma | 2022-03-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023021 | SCV002726383 | likely benign | not specified | 2022-04-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316620 | SCV004016534 | likely benign | Pancreatic cancer, susceptibility to, 1 | 2023-07-07 | criteria provided, single submitter | clinical testing |